Marty Hendrick, Executive Director
Oklahoma State Board of Pharmacy
2920 N. Lincoln Blvd., Suite A
Oklahoma City, OK 73105
Re: Castle, Case No. 2026-1748
Dear Executive Director Hendrick,
This office has received your request for a written Attorney General Opinion regarding disciplinary action the State Board of Pharmacy (the “Board”) intends to take in the above-referenced case. Respondent holds a pharmacy technician permit number T-4272 issued by the Oklahoma State Board of Pharmacy on February 1, 2000.
The Oklahoma Pharmacy Act authorizes the Board to regulate the practice of pharmacy. 59 O.S.Supp.2022, § 353.7. The Board has jurisdiction to hear this matter pursuant to Oklahoma Statute title 59, sections 353.7(12) and 353.26(A). The Board may revoke the license of any person who “[v]iolates any provision of the Oklahoma Pharmacy Act or any other applicable state or federal law;” or “[v]iolates any of the provisions of the Uniform Controlled Dangerous Substances Act;” or that “[c]onducts himself or herself in a manner likely to lower public esteem for the profession of pharmacy;” or “[e]xercises conduct and habits inconsistent with the rules of professional conduct established by the Board.” Id. § 353.26(A)(1), (2), (5), (8).[1] Pursuant to 59 O.S., § 353.24(A)(8), it is unlawful for any licensee or other person to “[p]ossess dangerous drugs without a valid prescription or a valid license to possess such drugs." See also OAC 535:25-9-7.
Respondent was a pharmacy technician at a retail pharmacy located in Lawton, Oklahoma, from on or about April 30, 2024, until her termination on October 23, 2025. On October 23, 2025, the Pharmacist-In-Charge of the pharmacy noticed tablets on the floor below Respondent as Respondent was filling prescriptions and asked if the tablets were coming from Respondent's clothes. Respondent admitted to the diversion of 30 tablets of Hydrocodone-Acetaminophen 10mg-325mg and was immediately asked to leave the premises. On October 23, 2025, Respondent was terminated from her employment for theft of a controlled substance.
The pharmacy initially submitted a DEA 106 Form noting 30 tablets of Hydrocodone Acetaminophen 10mg-325mg missing, until its internal investigation and counts were complete. An Amended DEA I 06 Form submitted on October 26, 2025, reported the loss of 1,538 tablets of Hydrocodone-Acetaminophen 10mg-325mg and 56 tablets of Dextroamp-Amphetamine 10 mg. On December 3, 2025, a criminal case was filed against Respondent in the Oklahoma District Court, Comanche County, Case No. CF-2025-710, bringing a felony charge against Respondent for Larceny, Burglary or Theft of Controlled Dangerous Substance (Hydrocodone-Acetaminophen). At the time of the filing of this Complaint, Case No. CF-2025-710 was still pending against Respondent (with a warrant for Respondent's arrest issued on December 5, 2025).
After a hearing on February 4, 2026, and considering the record in its totality, the Board concluded that the most appropriate disciplinary action is permanent revocation of Respondent's pharmacy technician permit and a monetary fine in the amount of $1,000.00.
The Board may reasonably believe the proposed action is necessary to deter future violations. It is, therefore, the official opinion of the Attorney General that the State Board of Pharmacy’s proposed action is in accordance with the State’s policy to protect public health, safety, and welfare.
Cheryl Dixon
Deputy General Counsel
[1] Respondent is required to “conduct business in conformity with all federal, state and municipal laws” and “conduct themselves . . . in a manner that will entitle them to the respect and confidence of the community in which they practice.” OAC 535:25-7-3(a), (b).
